Thought Leadership
A Checklist for eCOA Solution Deployment: Best Practices and Considerations
Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the...
Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions
This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for...
Successful English Build & Language Migration
Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the...
LifeSci Talks COA Series | More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner at Sprout Health Solutions, to discuss how pharma companies of all sizes can build a comprehensive, patient-centric...
When Licensing Becomes the Bottleneck: Lessons from a Sponsor on COAs, eCOA Vendors, and Getting It Right
FDA clinical outcome assessment strategy starts with licensing, translation, and vendor alignment. Learn how to protect trial integrity and keep patients first....
The Role of AI and Machine Learning in Clinical Outcome Assessment Translation
Automation can accelerate clinical workflows, but COA translation requires more than just AI on its own. Learn how to balance efficiency with scientific validity....
LifeSci Talks COA Series | Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a behind-the-scenes look at the reality of patient-centered instrument...
Back to the Basics: Foundations of COA Localization
COA translation isn’t as simple as swapping words from one language to another—patient concepts rarely map cleanly across cultures. This blog brings us back to the basics of clinical outcome assessment localization, breaking down why linguistic validation exists, what regulators...
Optimizing COA/eCOA Workflows with Technology for Better Quality & Timelines
Efficient workflows are critical to keeping global COA/eCOA studies on schedule while ensuring the quality of localized content. This live webinar will explore how technology stacks and automation can streamline clinical localization from start to finish, through integrating...
Integrating eCOAs and Digital Health for Patient-Centric Trials
Learn how eCOA integration with digital endpoints and connected platforms enhances patient engagement and operational efficiency in clinical trials....
Foundations of Clinical Outcome Assessment Localization
Accurate and culturally appropriate translation of clinical outcome assessments (COAs), including patient-reported outcome measures, is essential to ensuring reliable data in multinational trials. Foundations of Clinical Outcome Assessment Localization will provide a practical...
LifeSci Talks COA Series | Meaningful Patient Involvement in HTA Decision-making: Where do we go from here?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer, to discuss how PRO measures inform and impact endpoint adjudication and reimbursement decisions, due...
Integrating eCOAs and Digital Health Technologies for Patient-Centric Trials
The foundation of patient-first design is technology that connects seamlessly to support and meet patients where they are. In this session, leaders from Pfizer, THREAD, Datacubed, Obvio Health, and Merative will discuss how integrated digital ecosystems are breaking down platform...
LifeSci Talks COA Series | Silver Bullet or Useful Repositories: The Reality of Clinical Trial Libraries
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, is joined by Jonathan Norman, Director of Translation and Localization at YPrime, for an in-depth discussion on the realities of eCOA libraries. Together, they explore why ...
LifeSci Talks COA Series | Modernizing eCOA: Emulators, Backups, and the Future of Reporting
In this tech-forward episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, welcomes Indira Jain-Figueroa, Product Director at Evinova, for a deep dive into the ever-evolving landscape of eCOA development. Covering everything from cross...
Could Data Standardizations be the Silver Bullet for Faster Electronic Clinical Outcome Assessment (eCOA) Deployment?
Choosing an electronic clinical outcome assessment (eCOA) provider is a complex process that involves a variety of different aspects including experience, scientific support and knowledge, integration capabilities, scalability, study-specific requirements, and so much more. ...
LifeSci Talks COA Series | Balancing Innovation and Integrity: AI’s Place in Patient-Focused Research
Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with...
LifeSci Talks COA Series | Making the Most of Smaller Population Samples: Qualitative Insights in Rare Disease
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Kate Williams, Director of Patient-Centred Outcomes Research at Acaster Lloyd, to explore the nuances of gathering and applying qualitative data in rare disease...
AI in Clinical Outcome Assessment (COA): Challenges and Opportunities
In an increasingly interconnected and globalized world, effective cross-cultural communication is essential, making the development of accurate, efficient translation systems a top priority. ...
Avoiding Risk in Multilingual eCOA: FDA, EMA, and ISPOR Standards
Regulatory agencies worldwide, including the FDA, EMA, and other health authorities, require eCOA translations to be accurate, validated, and culturally adapted. ...
LifeSci Talks COA Series | Data Without Interpretation is Meaningless: Unlocking Inherent Value Within the Numbers
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Elizabeth (Nicki) Bush, Executive Director and Global Head of Endpoint Strategy and COA Measurement at OPEN Health Group to discuss the growing complexity of...
LifeSci Talks | Measuring What Matters: Modernizing Clinical Outcome Assessments with Patient-Centric Approaches
In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology at YPrime, to discuss the importance of embracing technology in clinical research to reduce the patient burden. The two cover...
LifeSci Talks | Effective Rater Training: A Critical but Overlooked Part of COA Administration
In this episode of LifeSci Talks, TransPerfect Life Sciences’ Global Practice Leader Mark Wade sits down with Kelly Dumais PhD, Director of eCOA Science at Clario to discuss the significance rater training plays in standardizing the administration and scoring of clinical scales....